当前位置：
X-MOL 学术
›
Lancet Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Correction to Lancet Oncol 2024; 25: 1188–201
The Lancet Oncology ( IF 41.6 ) Pub Date : 2024-10-30 , DOI: 10.1016/s1470-2045(24)00635-1
The Lancet Oncology ( IF 41.6 ) Pub Date : 2024-10-30 , DOI: 10.1016/s1470-2045(24)00635-1
Karpinski MJ, Hüsing J, Claassen K, et al Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study. Lancet Oncol 2024; 25: 1188–201—The appendix of this Article has been corrected as of Oct 30, 2024.
更新日期：2024-10-31
京公网安备 11010802027423号